Healthcare


 2 exciting small-cap healthcare shares on our watchlist - NAN and PGC

2 exciting small-cap healthcare shares on our watchlist - NAN and PGC

September 13, 2018 09:11 AM AEST| By Team Kalkine Media

Trophon 2 to push growth: Nanosonics Limited (ASX: NAN) failed to post good numbers in FY18 with the decline of almost 79% in the net income after tax at $5.75 Mn compared to $26.15 Mn in the previous comparable period. However, the major reason behi...

 One Healthcare stock on the watchlist - Nanosonic Limited

One Healthcare stock on the watchlist - Nanosonic Limited

September 13, 2018 07:00 AM AEST| By Team Kalkine Media

Nanosonics? stock continues to slide lower as the company?s revenue has squeezed in the financial year ended 30 June 2018. However, the FY18 results were in line with investor?s expectation as the company has heavily invested in its next generation T...

 Imagion Biosystems moves closer to first-in-human clinical study

Imagion Biosystems moves closer to first-in-human clinical study

September 11, 2018 07:37 AM AEST| By Team Kalkine Media

Healthcare company Imagion Biosystems has announced the success in achieving a key milestone of optimizing nanoparticle formulation in a drive to first-in-human testing. In the announcement to ASX on 10 September 2018, the company has reported succe...

 G Medical Innovations Enters Final Phase of Commercial Approval in China

G Medical Innovations Enters Final Phase of Commercial Approval in China

September 06, 2018 07:28 AM AEST| By Team Kalkine Media

G Medical Innovations (ASX: GMV) updated that regulatory audits for its facility in China are scheduled to be conducted towards the end of this month and the outcome would be released in early October. The audit would bring the company a step closer...

 Macquarie to sell its 95 million shares in Oceania Healthcare

Macquarie to sell its 95 million shares in Oceania Healthcare

September 05, 2018 03:59 PM AEST| By Team Kalkine Media

Macquarie Group (ASX: MQG) has gone on selling down some of its stakes in New Zealand based aged care service provider, Oceania Healthcare. As per the Oceania Healthcare?s disclosure to New Zealand Exchange, Macquarie Group has been found selling do...

 Federal funding cuts wiped out Regis’ earnings

Federal funding cuts wiped out Regis’ earnings

September 05, 2018 03:44 PM AEST| By Team Kalkine Media

Funding cuts by Federal government took away Regis Healthcare?s (ASX: REG) earnings as the ASX listed aged care services provider reported lower EBITDA of $117.1 million for the financial year ended 30 June 2018. This represents a 5% decline in grou...

 Starpharma’s DEP irinotecan showed significant anti-cancer efficacy with complete tumour regression

Starpharma’s DEP irinotecan showed significant anti-cancer efficacy with complete tumour regression

September 05, 2018 07:59 AM AEST| By Team Kalkine Media

Starpharma Holdings Limited?s (ASX: SPL) share price surged 3.387% to $1.282 after announcing that its proprietary DEP irinotecan development candidate showed complete tumour regression and 100% survival in a human pancreatic cancer model. This is co...

 Pro Medicus Limited (ASX: PME)- Pro Medicus’ shares are on fire today

Pro Medicus Limited (ASX: PME)- Pro Medicus’ shares are on fire today

September 03, 2018 01:07 PM AEST| By Team Kalkine Media

Pro Medicus? (ASX: PME) stock jumped 6.869% to $10.890 on 3 September 2018 after the healthcare technology company recently announced strong full years results for the period ended 30 June 2018. Profit after tax has gone up by 36.7% to $12.74 millio...

 Starpharma Holdings Limited (ASX: SPL)- Starpharma’s shares runs on getting first patent published

Starpharma Holdings Limited (ASX: SPL)- Starpharma’s shares runs on getting first patent published

August 31, 2018 03:00 PM AEST| By Team Kalkine Media

Starpharma?s stock price jumped 13.04% to $1.30 on 31 August 2018 after the AstraZeneca?s first patent application on Starpharma?s DEP dendrimer with AstraZeneca?s Bcl2/xL inhibitors got published by the World Intellectual Property organization. The...

 Zenitas’ stock rockets as consortium agrees to acquire 100% of Zenitas

Zenitas’ stock rockets as consortium agrees to acquire 100% of Zenitas

August 31, 2018 06:08 AM AEST| By Team Kalkine Media

Zenitas Healthcare (ASX: ZNT ) shares sky-rocketed 22.51% to $1.415 (31 August 2018; 1:50 PM AEST) on the release of scheme implementation deed announcing 100% of the Zenitas acquisition by Adamantem Capital and Liverpool Partners consortium for $1.4...

 Mesoblast Limited (ASX: MSB)- Mesoblast’s stock climbed on FY18 revenue growth

Mesoblast Limited (ASX: MSB)- Mesoblast’s stock climbed on FY18 revenue growth

August 30, 2018 04:01 PM AEST| By Team Kalkine Media

Mesoblast Limited (ASX: MSB) today announced full year financial results for the 12 months ended 30 June 2018.? Revenue increased by US$14.8 million to US$17.3 million benefitting from commercialization revenue on sales of TEMCELL and payments receiv...

 Ramsay Health Care Limited (ASX: RHC)- Ramsay Health Care arrowed down on ASX as net profit declined 20.6%

Ramsay Health Care Limited (ASX: RHC)- Ramsay Health Care arrowed down on ASX as net profit declined 20.6%

August 30, 2018 07:41 AM AEST| By Team Kalkine Media

Ramsay Health Care (ASX: RHC) reported 7.0% rise in core earnings per share to 279.8 cents and 6.8% rise in core net profit to $579.3 million for the year ended 30 June 2018. Group?s revenue increased 5.4% to $9.2 billion including 5.5% growth in Aus...

 Mesoblast Limited (ASX: MSB)- Mesoblast announces Chinese government approval to Tasly’s overseas investment

Mesoblast Limited (ASX: MSB)- Mesoblast announces Chinese government approval to Tasly’s overseas investment

August 29, 2018 10:18 AM AEST| By Team Kalkine Media

Mesoblast Limited (ASX: MSB) has today announced that Chinese pharmaceutical company Tasly Pharmaceutical Group has got China?s government approval of overseas direct investment to carry forward investment agreement as well as a development and colla...

 BWX Limited confirms the expectation of lower than anticipated earnings

BWX Limited confirms the expectation of lower than anticipated earnings

August 29, 2018 06:28 AM AEST| By Team Kalkine Media

BWX Limited (ASX: BWX) has finally released its results for the year ended 30 June 2018 which were earlier supposed to be announced on 15 August 2018. Earnings before interest tax, depreciation and amortization (EBITDA) downgraded on guidance range o...

 Blackmores Limited (ASX: BKL) – Rocketing on 19% growth in profit

Blackmores Limited (ASX: BKL) – Rocketing on 19% growth in profit

August 28, 2018 06:40 AM AEST| By Team Kalkine Media

Blackmores share price jumped up $16.24 after the company announced 19% hike in profit, thus delivering $70 million NPAT for the financial year ended 30 June 2018. Blackmores, (ASX: BKL) engaged in development, sales and marketing of health products...

 Fisher & Paykel Clocks New High On The Back Of New Product Launch

Fisher & Paykel Clocks New High On The Back Of New Product Launch

August 27, 2018 09:47 AM AEST| By Team Kalkine Media

Fisher & Paykel Healthcare Corp Ltd is into designing and marketing of the medical device products and system concerned with the respiratory care, acute care and the treatment of obstructive sleep apnea. The company has its footprints in North Am...

 Japara Healthcare Ltd reported 21.5% fall in the FY 18 net profit after tax

Japara Healthcare Ltd reported 21.5% fall in the FY 18 net profit after tax

August 27, 2018 09:06 AM AEST| By Team Kalkine Media

Weak Performance in FY 18: Japara Healthcare Ltd.?s (ASX: JHC) stock fell 4.4% on August 27, 2018 after the company reported 15.8% fall in FY18 EBITDA to $50.7 million and 21.5% fall in the net profit after tax (NPAT) to $23.3 million. [optin-monste...

 Monash IVF Group Ltd.’s stock is under pressure as the profit falls by 27.9% in FY 18

Monash IVF Group Ltd.’s stock is under pressure as the profit falls by 27.9% in FY 18

August 27, 2018 05:43 AM AEST| By Team Kalkine Media

Profit falls by 27.9% in FY 18: Monash IVF Group Ltd.?s (ASX: MVF) stock fell 6.6% on August 27, 2018 (3:20 PM AEST) after the company for FY 18 reported 27.9% fall in the profit to $21 million, 22.2% fall in EBITDA and 2.9% fall in the revenue to $1...

 Medibank Private Limited (ASX: MPL)- Medibank’s top line improved but bottom line disappointed

Medibank Private Limited (ASX: MPL)- Medibank’s top line improved but bottom line disappointed

August 24, 2018 02:07 PM AEST| By Team Kalkine Media

Healthcare company Medibank Private Limited today reported significant growth in operations for the fiscal year ended 30 June 2018. Group?s operating profit increased 9.7% to $548.8 million in FY18, which is largely attributable to Health Insurance?s...

 Mayne Pharma Group Limited (ASX: MYX)- Mayne continues to rise despite posting $133.9 million loss

Mayne Pharma Group Limited (ASX: MYX)- Mayne continues to rise despite posting $133.9 million loss

August 24, 2018 01:38 PM AEST| By Team Kalkine Media

Mayne Pharma?s net profit fell to negative $133.9 million despite recording strong performance in the second half of 2018. In 2H18 the ?reported? EBITDA increased 307% on 1H18, reflecting benefits derived from generic products performance growth, por...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.